This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An author's correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harada, J. N.
Right arrow Articles by Berk, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harada, J. N.
Right arrow Articles by Berk, A. J.

 Previous Article  |  Next Article 

Journal of Virology, July 1999, p. 5333-5344, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

p53-Independent and -Dependent Requirements for E1B-55K in Adenovirus Type 5 Replication

Josephine N. Harada and Arnold J. Berk*

Molecular Biology Institute, University of California---Los Angeles, Los Angeles, California 90095-1570

Received 14 January 1999/Accepted 24 March 1999

The adenovirus type 5 mutant dl1520 was engineered previously to be completely defective for E1B-55K functions. Recently, this mutant (also known as ONYX-015) has been suggested to replicate preferentially in p53- and some p53+ tumor cell lines but to be attenuated in primary cultured cells (C. Heise, A. Sampson-Johannes, A. Williams, F. McCormick, D. D. F. Hoff, and D. H. Kirn, Nat. Med. 3:639-645, 1997). It has been suggested that dl1520 might be used as a "magic bullet" that could selectively lyse tumor cells without harm to normal tissues. However, we report here that dl1520 replication is independent of p53 genotype and occurs efficiently in some primary cultured human cells, indicating that the mutant virus does not possess a tumor selectivity. Although it was not the sole host range determinant, p53 function did reduce dl1520 replication when analyzed in a cell line expressing temperature-sensitive p53 (H1299-tsp53) (K. L. Fries, W. E. Miller, and N. Raab-Traub, J. Virol. 70:8653-8659, 1996). As found earlier for other E1B-55K mutants in HeLa cells (Y. Ho, R. Galos, and J. Williams, Virology 122:109-124, 1982), dl1520 replication was temperature dependent in H1299 cells. When p53 function was restored at low temperature in H1299-tsp53 cells, it imposed a modest defect in viral DNA replication and accumulation of late viral cytoplasmic mRNA. However, in both H1299 and H1299-tsp53 cells, the defect in late viral protein synthesis appeared to be much greater than could be accounted for by the modest defects in late viral mRNA levels. We therefore propose that in addition to countering p53 function and modulating viral and cellular mRNA nuclear transport, E1B-55K also stimulates late viral mRNA translation.

* Corresponding author. Mailing address: Molecular Biology Institute, University of California, Los Angeles, 611 Charles Young Dr., Box 951570, Los Angeles, CA 90095-1570. Phone: (310) 206-6298. Fax: (310) 206-7286. E-mail: berk{at}mbi.ucla.edu.

Journal of Virology, July 1999, p. 5333-5344, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Blackford, A. N., Grand, R. J. A. (2009). Adenovirus E1B 55-Kilodalton Protein: Multiple Roles in Viral Infection and Cell Transformation. J. Virol. 83: 4000-4012 [Full Text]  
  • Leitner, S., Sweeney, K., Oberg, D., Davies, D., Miranda, E., Lemoine, N. R., Hallden, G. (2009). Oncolytic Adenoviral Mutants with E1B19K Gene Deletions Enhance Gemcitabine-induced Apoptosis in Pancreatic Carcinoma Cells and Anti-Tumor Efficacy In vivo. Clin. Cancer Res. 15: 1730-1740 [Abstract] [Full Text]  
  • Zheng, X., Rao, X.-M., Gomez-Gutierrez, J. G., Hao, H., McMasters, K. M., Zhou, H. S. (2008). Adenovirus E1B55K Region Is Required To Enhance Cyclin E Expression for Efficient Viral DNA Replication. J. Virol. 82: 3415-3427 [Abstract] [Full Text]  
  • Wakayama, M., Abei, M., Kawashima, R., Seo, E., Fukuda, K., Ugai, H., Murata, T., Tanaka, N., Hyodo, I., Hamada, H., Yokoyama, K. K. (2007). E1A, E1B Double-Restricted Adenovirus with RGD-Fiber Modification Exhibits Enhanced Oncolysis for CAR-Deficient Biliary Cancers. Clin. Cancer Res. 13: 3043-3050 [Abstract] [Full Text]  
  • Woo, J. L., Berk, A. J. (2007). Adenovirus Ubiquitin-Protein Ligase Stimulates Viral Late mRNA Nuclear Export. J. Virol. 81: 575-587 [Abstract] [Full Text]  
  • Hiraoka, K., Kimura, T., Logg, C. R., Kasahara, N. (2006). Tumor-Selective Gene Expression in a Hepatic Metastasis Model after Locoregional Delivery of a Replication-Competent Retrovirus Vector. Clin. Cancer Res. 12: 7108-7116 [Abstract] [Full Text]  
  • Gonzalez, R., Huang, W., Finnen, R., Bragg, C., Flint, S. J. (2006). Adenovirus E1B 55-Kilodalton Protein Is Required for both Regulation of mRNA Export and Efficient Entry into the Late Phase of Infection in Normal Human Fibroblasts. J. Virol. 80: 964-974 [Abstract] [Full Text]  
  • Liu, Y., Shevchenko, A., Shevchenko, A., Berk, A. J. (2005). Adenovirus Exploits the Cellular Aggresome Response To Accelerate Inactivation of the MRN Complex. J. Virol. 79: 14004-14016 [Abstract] [Full Text]  
  • Kamizono, J., Nagano, S., Murofushi, Y., Komiya, S., Fujiwara, H., Matsuishi, T., Kosai, K.-i. (2005). Survivin-Responsive Conditionally Replicating Adenovirus Exhibits Cancer-Specific and Efficient Viral Replication. Cancer Res. 65: 5284-5291 [Abstract] [Full Text]  
  • Wadler, S., Kaufman, H., Horwitz, M., Morley, S., Kirn, D., Brown, R., Kaye, S., Soutar, D. (2005). The dl1520 Virus Is Found Preferentially in Tumor Tissue after Direct Intratumoral Injection in Oral Carcinoma. Clin. Cancer Res. 11: 2781-2782 [Full Text]  
  • Curiel, D. T. (2005). Next Generation CRAds for Virotherapy of Cancer. aacredbook 2005: 141-144 [Full Text]  
  • Thorne, S. H., Brooks, G., Lee, Y.-L., Au, T., Eng, L. F., Reid, T. (2005). Effects of Febrile Temperature on Adenoviral Infection and Replication: Implications for Viral Therapy of Cancer. J. Virol. 79: 581-591 [Abstract] [Full Text]  
  • Abou El Hassan, M. A. I., van der Meulen-Muileman, I., Abbas, S., Kruyt, F. A. E. (2004). Conditionally Replicating Adenoviruses Kill Tumor Cells via a Basic Apoptotic Machinery-Independent Mechanism That Resembles Necrosis-Like Programmed Cell Death. J. Virol. 78: 12243-12251 [Abstract] [Full Text]  
  • Geoerger, B., Vassal, G., Opolon, P., Dirven, C. M. F., Morizet, J., Laudani, L., Grill, J., Giaccone, G., Vandertop, W. P., Gerritsen, W. R., van Beusechem, V. W. (2004). Oncolytic Activity of p53-Expressing Conditionally Replicative Adenovirus Ad{Delta}24-p53 against Human Malignant Glioma. Cancer Res. 64: 5753-5759 [Abstract] [Full Text]  
  • Chu, R. L., Post, D. E., Khuri, F. R., Van Meir, E. G. (2004). Use of Replicating Oncolytic Adenoviruses in Combination Therapy for Cancer. Clin. Cancer Res. 10: 5299-5312 [Abstract] [Full Text]  
  • Hobom, U., Dobbelstein, M. (2004). E1B-55-Kilodalton Protein Is Not Required To Block p53-Induced Transcription during Adenovirus Infection. J. Virol. 78: 7685-7697 [Abstract] [Full Text]  
  • Maemondo, M., Saijo, Y., Narumi, K., Kikuchi, T., Usui, K., Tazawa, R., Matsumoto, K., Nakamura, T., Sasaki, K., Takahashi, M., Niitsu, Y., Nukiwa, T. (2004). Gene Therapy with Secretory Leukoprotease Inhibitor Promoter-Controlled Replication-Competent Adenovirus for Non-Small Cell Lung Cancer. Cancer Res. 64: 4611-4620 [Abstract] [Full Text]  
  • Hann, B., Balmain, A. (2003). Replication of an E1B 55-Kilodalton Protein-Deficient Adenovirus (ONYX-015) Is Restored by Gain-of-Function Rather than Loss-of-Function p53 Mutants. J. Virol. 77: 11588-11595 [Abstract] [Full Text]  
  • Fukuda, K., Abei, M., Ugai, H., Seo, E., Wakayama, M., Murata, T., Todoroki, T., Tanaka, N., Hamada, H., Yokoyama, K. K. (2003). E1A, E1B Double-restricted Adenovirus for Oncolytic Gene Therapy of Gallbladder Cancer. Cancer Res. 63: 4434-4440 [Abstract] [Full Text]  
  • Xu, D., Falke, D., Juliano, R. L. (2003). P53-Dependent Cell-Killing by Selective Repression of Thymidine Kinase and Reduced Prodrug Activation. Mol. Pharmacol. 64: 289-297 [Abstract] [Full Text]  
  • Demers, G. W., Johnson, D. E., Tsai, V., Wen, S.-F., Quijano, E., Machemer, T., Philopena, J., Ramachandra, M., Howe, J. A., Shabram, P., Ralston, R., Engler, H. (2003). Pharmacologic Indicators of Antitumor Efficacy for Oncolytic Virotherapy. Cancer Res. 63: 4003-4008 [Abstract] [Full Text]  
  • Yan, W., Kitzes, G., Dormishian, F., Hawkins, L., Sampson-Johannes, A., Watanabe, J., Holt, J., Lee, V., Dubensky, T., Fattaey, A., Hermiston, T., Balmain, A., Shen, Y. (2003). Developing Novel Oncolytic Adenoviruses through Bioselection. J. Virol. 77: 2640-2650 [Abstract] [Full Text]  
  • Hecht, J. R., Bedford, R., Abbruzzese, J. L., Lahoti, S., Reid, T. R., Soetikno, R. M., Kirn, D. H., Freeman, S. M. (2003). A Phase I/II Trial of Intratumoral Endoscopic Ultrasound Injection of ONYX-015 with Intravenous Gemcitabine in Unresectable Pancreatic Carcinoma. Clin. Cancer Res. 9: 555-561 [Abstract] [Full Text]  
  • Hsieh, J.-L., Wu, C.-L., Lee, C.-H., Shiau, A.-L. (2003). Hepatitis B Virus X Protein Sensitizes Hepatocellular Carcinoma Cells to Cytolysis Induced by E1B-deleted Adenovirus through the Disruption of p53 Function. Clin. Cancer Res. 9: 338-345 [Abstract] [Full Text]  
  • Reid, T., Galanis, E., Abbruzzese, J., Sze, D., Wein, L. M., Andrews, J., Randlev, B., Heise, C., Uprichard, M., Hatfield, M., Rome, L., Rubin, J., Kirn, D. (2002). Hepatic Arterial Infusion of a Replication-selective Oncolytic Adenovirus (dl1520): Phase II Viral, Immunologic, and Clinical Endpoints. Cancer Res. 62: 6070-6079 [Abstract] [Full Text]  
  • Harada, J. N., Shevchenko, A., Shevchenko, A., Pallas, D. C., Berk, A. J. (2002). Analysis of the Adenovirus E1B-55K-Anchored Proteome Reveals Its Link to Ubiquitination Machinery. J. Virol. 76: 9194-9206 [Abstract] [Full Text]  
  • Gonzalez, R. A., Flint, S. J. (2002). Effects of Mutations in the Adenoviral E1B 55-Kilodalton Protein Coding Sequence on Viral Late mRNA Metabolism. J. Virol. 76: 4507-4519 [Abstract] [Full Text]  
  • Vasey, P. A., Shulman, L. N., Campos, S., Davis, J., Gore, M., Johnston, S., Kirn, D. H., O'Neill, V., Siddiqui, N., Seiden, M. V., Kaye, S. B. (2002). Phase I Trial of Intraperitoneal Injection of the E1B-55-kd-Gene-Deleted Adenovirus ONYX-015 (dl1520) Given on Days 1 Through 5 Every 3 Weeks in Patients With Recurrent/Refractory Epithelial Ovarian Cancer. JCO 20: 1562-1569 [Abstract] [Full Text]  
  • Holm, P. S., Bergmann, S., Jurchott, K., Lage, H., Brand, K., Ladhoff, A., Mantwill, K., Curiel, D. T., Dobbelstein, M., Dietel, M., Gansbacher, B., Royer, H.-D. (2002). YB-1 Relocates to the Nucleus in Adenovirus-infected Cells and Facilitates Viral Replication by Inducing E2 Gene Expression through the E2 Late Promoter. J. Biol. Chem. 277: 10427-10434 [Abstract] [Full Text]  
  • Ring, C. J. A. (2002). Cytolytic viruses as potential anti-cancer agents. J. Gen. Virol. 83: 491-502 [Abstract] [Full Text]  
  • Geoerger, B., Grill, J., Opolon, P., Morizet, J., Aubert, G., Terrier-Lacombe, M.-J., Bressac de-Paillerets, B., Barrois, M., Feunteun, J., Kirn, D. H., Vassal, G. (2002). Oncolytic Activity of the E1B-55 kDa-deleted Adenovirus ONYX-015 Is Independent of Cellular p53 Status in Human Malignant Glioma Xenografts. Cancer Res. 62: 764-772 [Abstract] [Full Text]  
  • Andreu, T., Ebensperger, C., Westphal, E.-M., Klenner, T., Stewart, A. F., Westhof, A., Muller, P., Knaus, R., von Melchner, H. (2001). Self-deleting Suicide Vectors (SDSV): Selective Killing of p53-deficient Cancer Cells. Cancer Res. 61: 6925-6930 [Abstract] [Full Text]  
  • Koch, P., Gatfield, J., Lober, C., Hobom, U., Lenz-Stoppler, C., Roth, J., Dobbelstein, M. (2001). Efficient Replication of Adenovirus Despite the Overexpression of Active and Nondegradable p53. Cancer Res. 61: 5941-5947 [Abstract] [Full Text]  
  • Dix, B. R., Edwards, S. J., Braithwaite, A. W. (2001). Does the Antitumor Adenovirus ONYX-015/dl1520 Selectively Target Cells Defective in the p53 Pathway?. J. Virol. 75: 5443-5447 [Full Text]  
  • Shen, Y., Kitzes, G., Nye, J. A., Fattaey, A., Hermiston, T. (2001). Analyses of Single-Amino-Acid Substitution Mutants of Adenovirus Type 5 E1B-55K Protein. J. Virol. 75: 4297-4307 [Abstract] [Full Text]  
  • Doronin, K., Kuppuswamy, M., Toth, K., Tollefson, A. E., Krajcsi, P., Krougliak, V., Wold, W. S. M. (2001). Tissue-Specific, Tumor-Selective, Replication-Competent Adenovirus Vector for Cancer Gene Therapy. J. Virol. 75: 3314-3324 [Abstract] [Full Text]  
  • Brunori, M., Malerba, M., Kashiwazaki, H., Iggo, R. (2001). Replicating Adenoviruses That Target Tumors with Constitutive Activation of the wnt Signaling Pathway. J. Virol. 75: 2857-2865 [Abstract] [Full Text]  
  • Heise, C., Lemmon, M., Kirn, D. (2000). Efficacy with a Replication-selective Adenovirus Plus Cisplatin-based Chemotherapy: Dependence on Sequencing but not p53 Functional Status or Route of Administration. Clin. Cancer Res. 6: 4908-4914 [Abstract] [Full Text]  
  • Russell, W. C. (2000). Update on adenovirus and its vectors. J. Gen. Virol. 81: 2573-2604 [Full Text]  
  • Nemunaitis, J., Ganly, I., Khuri, F., Arseneau, J., Kuhn, J., McCarty, T., Landers, S., Maples, P., Romel, L., Randlev, B., Reid, T., Kaye, S., Kirn, D. (2000). Selective Replication and Oncolysis in p53 Mutant Tumors with ONYX-015, an E1B-55kD Gene-deleted Adenovirus, in Patients with Advanced Head and Neck Cancer: A Phase II Trial. Cancer Res. 60: 6359-6366 [Abstract] [Full Text]  
  • Wildner, O., Morris, J. C. (2000). The Role of the E1B 55 kDa Gene Product in Oncolytic Adenoviral Vectors Expressing Herpes Simplex Virus-tk: Assessment of Antitumor Efficacy and Toxicity. Cancer Res. 60: 4167-4174 [Abstract] [Full Text]  
  • Doronin, K., Toth, K., Kuppuswamy, M., Ward, P., Tollefson, A. E., Wold, W. S. M. (2000). Tumor-Specific, Replication-Competent Adenovirus Vectors Overexpressing the Adenovirus Death Protein. J. Virol. 74: 6147-6155 [Abstract] [Full Text]  
  • Rogulski, K. R., Freytag, S. O., Zhang, K., Gilbert, J. D., Paielli, D. L., Kim, J. H., Heise, C. C., Kirn, D. H. (2000). In Vivo Antitumor Activity of ONYX-015 Is Influenced by p53 Status and Is Augmented by Radiotherapy. Cancer Res. 60: 1193-1196 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»